Pediatrics Doctors in Enterprise, AL Accepting Medicare

9 Pediatrics doctors found. Showing 1 - 9

Dr. Rodd Daniel Whitaker, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 Professional Lane, Enterprise, AL 36330 Phone: 334-347-3404    Fax: 334-393-0613

Norma P Samuy, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 105 E Watts St, Enterprise, AL 36330 Phone: 334-393-5437    Fax: 334-393-4185

Nola Jean Ernest, M.D., PH.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 526 Boll Weevil Cir, Enterprise Pediatric Clinic, Enterprise, AL 36330 Phone: 334-308-1166    Fax: 334-308-1019

Dr. Alexander Mark Eisen, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 105 E Watts St, Enterprise, AL 36330 Phone: 334-393-5437    Fax: 334-393-4185

Dr. William A Gammill, DO Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 101 E Brunson St, Suite 200, Enterprise, AL 36330 Phone: 334-393-3686    Fax: 334-347-4906

Dr. Maria Aurora Canlas Sucgang, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 101 Professional Ln, Enterprise, AL 36330 Phone: 334-347-3404    Fax: 334-393-0613

Mrs. Jamie T. Hixon-griffin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 526 Boll Weevil Cir, Enterprise, AL 36330 Phone: 334-308-1166    Fax: 334-308-1019

Misty Michelle Parker, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 101 Professional Ln # A, Enterprise, AL 36330 Phone: 334-347-3404

Dr. Stephen Raymond Brandt, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 105 E Watts St, Enterprise, AL 36330 Phone: 334-393-5437    Fax: 334-393-4185

News Archive

Research: Specific gene action during exposure to adolescent trauma is critical for development of PTSD

Research led by Ya-Ping Tang, MD, PhD, Associate Professor of Cell Biology and Anatomy at LSU Health Sciences Center New Orleans, has found that the action of a specific gene occurring during exposure to adolescent trauma is critical for the development of adult-onset Post-Traumatic Stress Disorder (PTSD.)

FDA issues Lux Biosciences Complete Response letter for Luveniq NDA

Lux Biosciences, Inc. today announced that the U.S. Food and Drug Administration's Center of Drug Evaluation and Research has issued a Complete Response letter regarding the New Drug Application (NDA) for Luveniq™ (oral voclosporin) for the treatment of non-infectious uveitis.

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

Study sheds light on complexities of cancer genetics

By studying fruit flies, scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have successfully devised a fast and cost-saving way to uncover genetic changes that have a higher potential to cause cancer.

Read more Medical News

› Verified 1 days ago